AstraZeneca sells off drugs to streamline portfolio
Monday, August 3, 2015 - 03:50
in Health & Medicine
Crohn’s disease and rare thyroid cancer drugs lie outside firm’s renewed strategic focus
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via